Stock listing

NASDAQ:APYX Apyx Medical Corporation Stock

Home listing (NASDAQ) of Apyx Medical Corporation

Follow Apyx Medical Corporation into a list and get an email when it puts out news.

Share price · NASDAQ:APYX

$2.40 USD -0.09 (-3.6%)

Close on Nov 20, 2026

Past year -40.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$2.35 – $2.46 USDNov 20, 2026
Volume
100,118 sharesNov 20, 2026
Market cap
$101.1M USDAt the close on Nov 20, 2026 · price × 42.12M shares outstanding
52-week range
$2.25 – $5.08 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$399,125 USDMedian day 90,900 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Apyx Medical Corporation logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:APYX · Home$2.40 USD-0.09 (-3.6%)100,118$2.44$2.46$2.35$2.49Close on Nov 20, 2026
Frankfurt:BOV€2.12 EUR0.00 (0.0%)—€2.10€2.12€2.10€2.12Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:APYX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.40-0.09-3.6%$2.44$2.46$2.35100,118
$2.49-0.065-2.5%$2.52$2.57$2.385188,655
$2.555-0.095-3.6%$2.67$2.67$2.4046,115
$2.65-0.16-5.7%$2.886$2.886$2.5371,230
$2.81-0.08-2.8%$2.795$2.81$2.6643,008
$2.89-0.11-3.7%$2.93$2.93$2.772128,115
$3.00+0.07+2.4%$3.08$3.096$2.91534,178
$2.93-0.01-0.3%$2.96$3.02$2.8863,858
$2.94+0.01+0.3%$2.96$3.05$2.9272,336
$2.93-0.13-4.2%$3.05$3.30$2.88201,253
$3.06+0.47+18.1%$2.60$3.107$2.575994,628
$2.59-0.01-0.4%$2.65$2.67$2.55144,846
$2.600.000.0%$2.59$2.65$2.5764,895
$2.600.000.0%$2.58$2.80$2.53116,200
$2.60-0.09-3.3%$2.65$2.65$2.5338,090
$2.69+0.08+3.1%$2.60$2.69$2.4867,399
$2.61+0.11+4.4%$2.53$2.61$2.51534,756
$2.50+0.04+1.6%$2.45$2.527$2.4146,239
$2.46+0.09+3.8%$2.37$2.47$2.35128,806
$2.37-0.04-1.7%$2.39$2.40$2.25146,157
$2.41-0.10-4.0%$2.46$2.53$2.34187,326
$2.51+0.07+2.9%$2.47$2.513$2.4270,315
$2.44+0.02+0.8%$2.45$2.56$2.42366,566
$2.42-0.13-5.1%$2.55$2.56$2.35223,589
$2.55-0.01-0.4%$2.60$2.65$2.5454,000
$2.56-0.01-0.4%$2.45$2.58$2.45151,900
$2.57-0.03-1.2%$2.59$2.59$2.4938,700
$2.60-0.05-1.9%$2.68$2.68$2.48148,800
$2.65+0.06+2.3%$2.62$2.73$2.5380,000
$2.59+0.23+9.7%$2.38$2.62$2.38103,500
$2.36-0.19-7.5%$2.54$2.54$2.34231,400
$2.55+0.005+0.2%$2.52$2.60$2.4934,800
$2.545-0.055-2.1%$2.63$2.63$2.53129,300
$2.60+0.05+2.0%$2.53$2.63$2.5068,400
$2.55+0.05+2.0%$2.51$2.60$2.5051,700
$2.50+0.05+2.0%$2.46$2.62$2.42294,900
$2.45-0.15-5.8%$2.58$2.827$2.45639,600
$2.60+0.10+4.0%$2.63$2.65$2.46338,500
$2.50-0.46-15.5%$2.90$2.95$2.32362,300
$2.96+0.13+4.6%$2.85$2.97$2.85131,400
$2.83-0.12-4.1%$2.96$2.96$2.8373,800
$2.950.000.0%$2.92$2.962$2.8986,100
$2.95+0.04+1.4%$2.93$2.98$2.9173,900
$2.91-0.15-4.9%$3.06$3.075$2.86169,100
$3.06+0.03+1.0%$3.03$3.063$3.00152,700
$3.03+0.02+0.7%$3.04$3.11$3.0034,200
$3.01+0.05+1.7%$2.97$3.075$2.9081,000
$2.96-0.06-2.0%$3.03$3.03$2.9044,100
$3.02+0.12+4.1%$2.88$3.03$2.87589,100
$2.90+0.01+0.3%$2.90$3.07$2.79161,300
$2.89-0.16-5.2%$3.05$3.07$2.8790,900
$3.050.000.0%$3.05$3.055$3.0070,400
$3.050.000.0%$2.97$3.07$2.97128,500
$3.05-0.01-0.3%$3.06$3.08$3.0262,100
$3.06-0.02-0.6%$3.08$3.08$2.96144,000
$3.08+0.03+1.0%$3.07$3.11$3.0526,000
$3.050.000.0%$3.07$3.11$3.01100,400
$3.05-0.03-1.0%$3.05$3.189$3.0246,700
$3.08+0.08+2.7%$3.01$3.22$3.00115,300
$3.00-0.05-1.6%$3.05$3.05$2.825815,900
$3.05-0.06-1.9%$3.12$3.12$2.99116,700
$3.11+0.03+1.0%$3.12$3.24$3.0948,430
$3.08-0.04-1.3%$3.13$3.19$2.98119,571
$3.12+0.09+3.0%$3.05$3.17$3.0452,900
$3.03-0.12-3.8%$3.15$3.29$3.0388,800
Ticker
NASDAQ:APYX
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Apyx Medical Corporation news

Apyx Medical Corporation on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
21 in the last 12 months · 109 in all · newest Nov 5, 2026 · oldest 2019
Calls
31 calls with a replay · 31 with a transcript · latest Nov 5, 2026
Decks
13 decks · latest November 2026

Where Apyx Medical Corporation is listed

ListingExchangeCountryCurrency
NASDAQ:APYX · Home listing · This pageNASDAQUnited StatesUSD
gettex:BOVgettexGermanyEUR
BOATS:APYXBOATSUnited StatesUSD
LS Exchange:A2PBJCLS ExchangeGermanyEUR
Lang & Schwarz:A2PBJCLang & SchwarzGermanyEUR
Dusseldorf:BOVDusseldorfGermanyEUR
Stuttgart:BOVStuttgartGermanyEUR
Frankfurt:BOVFrankfurtGermanyEUR
Munich:BOVMunichGermanyEUR
Tradegate:BOVTradegateGermanyEUR

Valuation

EV/sales 1.9× against a median of 1.4×: 7th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$112.8M USD
P/E
Loss
EV/sales
1.9×
EV/EBITDA
Negative EBITDA
Price/book
10.5×
Gross margin
63.4%
Operating margin
−5.5%
Net margin
−14.2%
Debt to equity
3.9×
Beta vs S&P 500
0.85

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Apyx Medical Corporation · NASDAQ:APYXUS$101.1MUS$112.8Mn/a1.9×n/a10.5×−14.2%3.9×0.85
Aroa Biosurgery Ltd · ASX:ARXUS$112.6MUS$101.1M40.9×1.7×16.9×2.1×4.5%0.1×n/a
Pulmonx Corporation · NASDAQ:LUNGUS$111.9MUS$97.15Mn/a1.1×n/a3.3×−47.9%1.1×1.95
Laxmi Dental Ltd. · NSE:LAXMIDENTLUS$111.4MUS$110.1M31.9×3.5×20.4×3.9×11.0%0.1×n/a
Onward Medical N.V. · EURONEXT:ONWDUS$106.1MUS$31.75Mn/a5.3×n/a1.3×−771.8%0.2×n/a
Interojo Inc. · KRX:119610US$105.7MUS$84.13M8.0×0.9×3.4×0.9×14.3%0.0×n/a
Orthocell Ltd · ASX:OCCUS$102.8MUS$74.57Mn/a9.9×n/a4.5×−122.0%0.1×n/a
Sisram Medical Ltd. · HKEX:1696US$101.5MUS$103.1M5.3×0.3×2.1×0.2×5.2%0.2×n/a
Thai Optical Group Public Co. Ltd. · SET:TOGUS$98.05MUS$103.0M9.4×1.0×5.1×1.3×9.9%0.1×n/a
Stereotaxis, Inc. · AMEX:STXSUS$94.41MUS$92.90Mn/a3.0×n/a4.4×−70.9%0.1×1.03
Gaush Meditech Ltd. · HKEX:2407US$94.33MUS$101.0M6.5×0.5×3.2×0.4×7.0%0.2×n/a
Median of the othersUS$104.2MUS$99.07M8.7×1.4×4.3×1.7×4.9%0.1×1.49

Forecasts

4 strong buy · 2 buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
6.50 USD · Analysts' mean
EPS, year to Dec 2026
-0.20 · 5 analysts
Revenue, year to Dec 2026
59.59M · 6 analysts

Team and board

Officers

OfficerRole
Charlie GoodwinPresident and Chief Executive Officer

Board

DirectorRole
Andrew MakridesChairman of the Board
Stavros VizirgianakisChairman of the Board

Events

Calls

CallWhenStatus
Apyx Medical (NASDAQ:APYX) Q3 2026 Earnings CallThu, Nov 05, 2026 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q2 2026 Earnings CallThu, Aug 06, 2026 · 4:30 PM ETReplay
Apyx Medical (NASDAQ:APYX) Q1 2026 Earnings CallThu, May 07, 2026 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q4 2025 Earnings CallTue, Mar 10, 2026 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q3 2025 Earnings CallThu, Nov 06, 2025 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q2 2025 Earnings CallThu, Aug 07, 2025 · 4:30 PM ETReplay
Apyx Medical (NASDAQ:APYX) Q1 2025 Earnings CallThu, May 08, 2025 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q4 2024 Earnings CallThu, Mar 13, 2025 · 8:30 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q3 2024 Earnings CallFri, Nov 08, 2024 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q2 2024 Earnings CallThu, Aug 08, 2024 · 5:00 PM ETReplay
All 31 calls
CallWhenStatus
Apyx Medical (NASDAQ:APYX) Q1 2024 Earnings CallThu, May 09, 2024 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q4 2023 Earnings CallMon, Jan 08, 2024 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q3 2023 Earnings CallThu, Nov 09, 2023 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q2 2023 Earnings CallThu, Aug 10, 2023 · 5:00 PM ETReplay
Apyx Medical (NASDAQ:APYX) Q1 2023 Earnings CallThu, May 11, 2023 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q4 2022 Earnings CallThu, Mar 16, 2023 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q3 2022 Earnings CallThu, Nov 10, 2022 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q2 2022 Earnings CallThu, Aug 11, 2022 · 5:00 PM ETReplay
Apyx Medical (NASDAQ:APYX) Q1 2022 Earnings CallThu, May 12, 2022 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q4 2021 Earnings CallThu, Mar 17, 2022 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q3 2021 Earnings CallThu, Nov 11, 2021 · 5:00 PM ETReplay
Apyx Medical (NASDAQ:APYX) Q2 2021 Earnings CallThu, Aug 12, 2021 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q1 2021 Earnings CallWed, May 12, 2021 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q4 2020 Earnings CallWed, Mar 31, 2021 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q3 2020 Earnings CallMon, Nov 09, 2020 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q2 2020 Earnings CallMon, Aug 10, 2020 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q1 2020 Earnings CallMon, May 11, 2020 · 8:00 AM ETReplay
Apyx Medical (NASDAQ:APYX) Q4 2019 Earnings CallMon, Mar 16, 2020 · 5:00 PM ETReplay
Apyx Medical (NASDAQ:APYX) Q3 2019 Earnings CallMon, Nov 11, 2019 · 4:30 PM ETReplay
Apyx Medical (NASDAQ:APYX) Q2 2019 Earnings CallThu, Aug 08, 2019 · 4:30 PM ETReplay
Apyx Medical (NASDAQ:APYX) Q1 2019 Earnings CallWed, May 08, 2019 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · Before open+18.1%
Q2 2026Aug 6, 2026 · After close−2.6%
Q1 2026May 7, 2026 · Before open+21.9%
Q4 2025Mar 10, 2026+14.6%
Q3 2025Nov 6, 2025 · Before open+6.7%
Q2 2025Aug 7, 2025 · After close+11.2%
Q1 2025May 7, 2025 · Before open+16.8%
Q4 2024Mar 13, 2025 · Before open−2.8%
Q3 2024Nov 8, 2024 · Before open+24.6%
Q2 2024Aug 8, 2024 · After close+2.0%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · Before open+23.0%
Q4 2023Mar 21, 2024 · Before open−28.6%
Q3 2023Nov 9, 2023 · Before open−20.3%
Q2 2023Aug 10, 2023 · After close+20.1%
Q1 2023May 11, 2023 · Before open+28.7%
Q4 2022Mar 16, 2023 · Before open+10.7%
Q3 2022Nov 10, 2022 · Before open−60.5%
Q2 2022Aug 11, 2022 · After close−19.8%
Q1 2022May 12, 2022 · Before open+7.7%
Q4 2021Mar 17, 2022 · Before open+14.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck20 slidesNovember 2026
Investor Presentation (August 2026)Investor deck20 slidesAugust 2026
Q1 2026 Earnings PresentationEarnings18 slidesMay 7, 2026
Investor Presentation (May 2026)Investor deck18 slidesMay 2026
Investor Presentation (January 2026)Investor deck18 slidesJanuary 2026
Investor Presentation (March 2025)Investor deck24 slidesMarch 2025
Investor Presentation (January 2025)Investor deck24 slidesJanuary 2025
Investor Presentation (August 2024)Investor deck24 slidesAugust 2024
Investor Presentation (June 2024)Investor deck25 slidesJune 2024
Investor Presentation (April 2024)Investor deck27 slidesApril 2024
All 13 decks
DeckKindSlidesDate
Investor Presentation (January 2024)Investor deck28 slidesJanuary 2024
Investor Presentation (August 2023)Investor deck27 slidesAugust 2023
Investor Presentation (November 2021)Investor deck27 slidesNovember 2021

Open Decks

Financings

RaiseDate
Public offering of shares of common stock (or common stock equivalents)
Announced: Lucid Capital Markets
Dealers: Lucid Capital Markets (lead)
Nov 17, 2025

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue52.8M48.1M52.3M44.5M48.5M27.7M28.2M16.6M10.2M8.82M
Cost of revenue19.8M18.7M18.6M15.4M14.9M10.2M9.14M5.78M3.28M3.70M
Gross profit33.0M29.4M33.8M29.1M33.6M17.5M19.1M10.8M6.96M5.12M
Research and development3.37M5.08M5.44M4.54M4.32M3.92M3.73M2.55M1.94M1.03M
Selling, general and administrative15.8M18.9M22.2M20.5M18.6M11.7M13.7M9.41M8.69M6.18M
Operating income-6.45M-18.8M-17.3M-23.6M-14.4M-20.1M-20.9M-14.3M-13.9M-11.4M
Depreciation and amortization655.0K599.0K692.0K890.0K903.0K887.0K754.0K669.0K696.0K734.0K
EBITDA-5.79M-18.2M-16.6M-22.7M-13.5M-19.2M-20.1M-13.6M-13.2M-10.7M
Interest expense5.59M5.91M2.48M15.0K10.0K46.0K8.00K104.0K136.0K158.0K
Income before tax-10.8M-23.3M-21.3M-22.9M-14.8M-19.4M-19.8M-14.7M-13.8M-11.5M
Income tax270.0K252.0K-2.43M367.0K380.0K-7.50M-130.0K-3.91M-156.0K64.0K
Net income-11.2M-23.5M-18.7M-23.2M-15.2M-11.9M-19.7M62.7M-5.06M-11.6M
Earnings per share, basic-0.27-0.66-0.54-0.67-0.44-0.35-0.581.89-0.16-0.14
Earnings per share, diluted-0.54-0.67-0.44-0.35-0.581.83-0.17-0.15

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents31.7M31.7M43.7M10.2M30.9M41.9M58.8M16.6M9.95M14.5M
Short-term investments39.7M061.7M0779.0K
Receivables16.8M15.5M14.0M10.6M13.0M8.40M7.99M5.08M4.86M4.73M
Inventory8.60M7.56M9.92M11.8M6.78M4.05M5.07M5.30M4.27M6.16M
Current assets58.5M56.4M70.4M43.0M60.7M66.1M76.7M89.8M22.5M26.5M
Property, plant and equipment2.37M1.99M1.92M6.76M6.58M6.54M6.62M5.79M6.03M6.45M
Goodwill185.0K185.0K185.0K
Total assets66.8M64.8M79.2M51.8M68.7M74.1M84.7M95.9M31.0M35.1M
Accounts payable3.06M2.62M2.71M2.67M2.63M1.51M2.44M1.42M1.58M1.61M
Current liabilities11.7M10.7M12.7M11.8M13.2M9.15M12.3M8.61M5.97M5.27M
Long-term debt34.8M33.9M33.2M002.46M2.69M
Total debt37.5M37.5M33.2M0305.0K676.0K1.13M02.69M2.93M
Total liabilities52.0M50.5M52.3M14.0M14.7M10.3M13.5M8.75M8.96M8.89M
Shareholders' equity14.5M14.2M26.7M37.6M53.7M63.7M71.3M87.2M22.0M26.2M
Shares outstanding41.8M37.8M34.6M34.6M34.4M34.3M34.2M33.7M32.9M30.9M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-8.00M-18.0M-5.25M-20.3M-10.4M-16.1M-18.5M-20.9M-3.70M-2.84M
Capital spending-1.11M-722.0K-533.0K-1.01M-723.0K-581.0K-1.30M-363.0K-624.0K-286.0K
Free cash flow-9.12M-18.8M-5.78M-21.3M-11.2M-16.6M-19.8M-21.2M-4.33M-3.12M
Cash from investing-1.11M-722.0K6.73M-1.01M-723.0K-581.0K60.5M29.3M-624.0K-286.0K
Cash from financing9.58M6.75M32.2M217.0K24.0K-73.0K147.0K-2.49M-239.0K5.71M
Share buybacks195.0K148.0K207.0K202.0K5.83M
Change in cash-1.00K-11.9M33.5M-20.7M-11.0M-16.9M42.2M5.93M-4.57M2.65M

Open Financials

Filings

FilingDateTypeFiled with
S-8 · Registration statement for employee plansNov 19, 2026Offer documentSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeOct 28, 2026Big-stake noticeSEC
8-K · Current reportSep 29, 2026Current reportSEC
8-K · Current reportAug 7, 2026Management or board changeSEC
10-Q · Quarterly reportAug 6, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
8-K · Current reportJul 24, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 21, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJul 2, 2026Insider tradeSEC
DEF 14A · Proxy statementJun 26, 2026Meeting noticeSEC
4 · Change in ownershipJun 17, 2026Insider tradeSEC
8-K · Current reportJun 17, 2026Material contractSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
SD · Specialized disclosureJun 1, 2026ESG reportSEC
8-K · Current reportMay 21, 2026Current reportSEC
8-K · Current reportMay 14, 2026Current reportSEC
8-K · Current reportMay 11, 2026Current reportSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
10-K · Annual reportMar 10, 2026Annual reportSEC
8-K · Current reportMar 10, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
4 · Change in ownershipJan 29, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 20, 2026Big-stake noticeSEC
8-K · Current reportJan 12, 2026ResultsSEC
EFFECT · Notice that a registration is effectiveDec 17, 2025Other filingsSEC
8-K · Current reportDec 12, 2025Current reportSEC
CORRESP · Letter to the SECDec 12, 2025Other filingsSEC
S-3 · Registration statementDec 1, 2025Offer documentSEC
8-K · Current reportNov 19, 2025Material contractSEC
424B5 · ProspectusNov 18, 2025Offer documentSEC
424B5 · ProspectusNov 17, 2025Offer documentSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
8-K · Current reportAug 13, 2025Meeting outcomeSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
DEF 14A · Proxy statementJun 25, 2025Meeting noticeSEC
PRE 14A · Preliminary proxy statementJun 13, 2025Meeting noticeSEC
SD · Specialized disclosureMay 30, 2025ESG reportSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
8-K · Current reportMay 13, 2025Current reportSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
8-K · Current reportApr 29, 2025Current reportSEC
10-K · Annual reportMar 13, 2025Annual reportSEC
8-K · Current reportMar 13, 2025ResultsSEC
4/A · Change in ownership, amendedMar 3, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeFeb 14, 2025Big-stake noticeSEC
8-K · Current reportFeb 6, 2025Management or board changeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
4 · Change in ownershipJan 17, 2025Insider tradeSEC
3 · Initial statement of ownershipJan 17, 2025Insider tradeSEC
8-K · Current reportJan 13, 2025ResultsSEC
8-K · Current reportJan 6, 2025Current reportSEC
10-Q · Quarterly reportNov 8, 2024Quarterly reportSEC
424B5 · ProspectusNov 8, 2024Offer documentSEC
8-K · Current reportNov 8, 2024ResultsSEC
SC 13G · Big-stake noticeOct 31, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedOct 15, 2024Big-stake noticeSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
4 · Change in ownershipAug 12, 2024Insider tradeSEC
8-K · Current reportAug 12, 2024Meeting outcomeSEC
10-Q · Quarterly reportAug 8, 2024Quarterly reportSEC
8-K · Current reportAug 8, 2024ResultsSEC
DEF 14A · Proxy statementJun 25, 2024Meeting noticeSEC
SD · Specialized disclosureMay 31, 2024ESG reportSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
3 · Initial statement of ownershipMay 9, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedMay 9, 2024Big-stake noticeSEC
8-K · Current reportMay 9, 2024ResultsSEC
8-K · Current reportMay 9, 2024Material contractSEC
SC 13D · Big-stake noticeApr 5, 2024Big-stake noticeSEC
SC 13D · Big-stake noticeApr 1, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedMar 25, 2024Big-stake noticeSEC
10-K · Annual reportMar 21, 2024Annual reportSEC
8-K · Current reportMar 21, 2024ResultsSEC
8-K · Current reportFeb 21, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 7, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 2, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeJan 23, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJan 23, 2024Big-stake noticeSEC
8-K · Current reportJan 22, 2024Current reportSEC
4 · Change in ownershipJan 11, 2024Insider tradeSEC
4 · Change in ownershipJan 11, 2024Insider tradeSEC
4 · Change in ownershipJan 11, 2024Insider tradeSEC
4 · Change in ownershipJan 11, 2024Insider tradeSEC
8-K · Current reportJan 8, 2024ResultsSEC
4 · Change in ownershipDec 14, 2023Insider tradeSEC
3 · Initial statement of ownershipDec 6, 2023Insider tradeSEC
8-K · Current reportNov 28, 2023Management or board changeSEC
S-8 · Registration statement for employee plansNov 16, 2023Offer documentSEC
8-K · Current reportNov 16, 2023Management or board changeSEC
S-8 · Registration statement for employee plansNov 16, 2023Offer documentSEC
4 · Change in ownershipNov 15, 2023Insider tradeSEC
8-K · Current reportNov 9, 2023Material contractSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
8-K · Current reportNov 9, 2023ResultsSEC
8-K · Current reportAug 16, 2023Meeting outcomeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
4 · Change in ownershipAug 15, 2023Insider tradeSEC
SC 13G · Big-stake noticeAug 14, 2023Big-stake noticeSEC
10-Q · Quarterly reportAug 10, 2023Quarterly reportSEC
8-K · Current reportAug 10, 2023ResultsSEC
4 · Change in ownershipJul 19, 2023Insider tradeSEC
4/A · Change in ownership, amendedJun 29, 2023Insider tradeSEC
4 · Change in ownershipJun 28, 2023Insider tradeSEC
DEF 14A · Proxy statementJun 23, 2023Meeting noticeSEC
144 · Notice of proposed saleJun 21, 2023Other filingsSEC
SC 13G/A · Big-stake notice, amendedJun 12, 2023Big-stake noticeSEC
4 · Change in ownershipJun 9, 2023Insider tradeSEC
SD · Specialized disclosureMay 31, 2023ESG reportSEC
SC 13G · Big-stake noticeMay 19, 2023Big-stake noticeSEC
SC 13G · Big-stake noticeMay 12, 2023Big-stake noticeSEC
10-Q · Quarterly reportMay 11, 2023Quarterly reportSEC
8-K · Current reportMay 11, 2023ResultsSEC
8-K · Current reportApr 18, 2023Material contractSEC
4 · Change in ownershipMar 22, 2023Insider tradeSEC
10-K · Annual reportMar 16, 2023Annual reportSEC
8-K · Current reportMar 16, 2023ResultsSEC
8-K · Current reportMar 15, 2023Material contractSEC
8-K · Current reportFeb 24, 2023Material contractSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2023Big-stake noticeSEC
4 · Change in ownershipJan 13, 2023Insider tradeSEC
4 · Change in ownershipJan 13, 2023Insider tradeSEC
4 · Change in ownershipJan 13, 2023Insider tradeSEC
4 · Change in ownershipJan 13, 2023Insider tradeSEC
SC 13G/A · Big-stake notice, amendedJan 11, 2023Big-stake noticeSEC
8-K · Current reportJan 10, 2023ResultsSEC
EFFECT · Notice that a registration is effectiveDec 5, 2022Other filingsSEC
S-3/A · Registration statement, amendedDec 2, 2022Offer documentSEC
CORRESP · Letter to the SECNov 30, 2022Other filingsSEC
UPLOAD · Letter from the SECNov 30, 2022Other filingsSEC
SC 13G · Big-stake noticeNov 22, 2022Big-stake noticeSEC
S-3 · Registration statementNov 22, 2022Offer documentSEC
SC 13G/A · Big-stake notice, amendedNov 21, 2022Big-stake noticeSEC
10-Q · Quarterly reportNov 10, 2022Quarterly reportSEC
8-K · Current reportNov 10, 2022ResultsSEC
4 · Change in ownershipAug 31, 2022Insider tradeSEC
4 · Change in ownershipAug 17, 2022Insider tradeSEC
8-K · Current reportAug 17, 2022Meeting outcomeSEC
4 · Change in ownershipAug 17, 2022Insider tradeSEC
4 · Change in ownershipAug 17, 2022Insider tradeSEC
4 · Change in ownershipAug 17, 2022Insider tradeSEC
4 · Change in ownershipAug 17, 2022Insider tradeSEC
4 · Change in ownershipAug 17, 2022Insider tradeSEC
4 · Change in ownershipAug 17, 2022Insider tradeSEC
10-Q · Quarterly reportAug 11, 2022Quarterly reportSEC
8-K · Current reportAug 11, 2022ResultsSEC
8-K · Current reportJul 18, 2022Current reportSEC
4 · Change in ownershipJul 12, 2022Insider tradeSEC
4 · Change in ownershipJul 11, 2022Insider tradeSEC
4 · Change in ownershipJul 11, 2022Insider tradeSEC
4 · Change in ownershipJul 11, 2022Insider tradeSEC
SC 13G · Big-stake noticeJul 8, 2022Big-stake noticeSEC
DEF 14A · Proxy statementJun 24, 2022Meeting noticeSEC
8-K · Current reportJun 13, 2022Current reportSEC
SD · Specialized disclosureMay 27, 2022ESG reportSEC
8-K · Current reportMay 26, 2022Current reportSEC
4 · Change in ownershipMay 23, 2022Insider tradeSEC
4 · Change in ownershipMay 19, 2022Insider tradeSEC
10-Q · Quarterly reportMay 12, 2022Quarterly reportSEC

This page holds 200 of 993 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Apyx Medical Corporation’s releases · as of Nov 4, 2026

Common shares
42,124,023
Fully diluted
42,124,023

Fully diluted

LineSharesAs of
Common shares42,124,023Nov 4, 2026

Share count over time

CountShares
Nov 4, 202642,124,023

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Royce & Associates LP3.5M8.3%US$8.58MSep 30, 2026
Nantahala Capital Management, LLC3.34M7.9%US$8.19MSep 30, 2026
Archon Capital Management LLC2.64M6.3%US$6.48MSep 30, 2026
Vanguard1.77M4.2%US$4.34MSep 30, 2026
Kanen Wealth Management LLC1.55M3.7%US$3.82MSep 30, 2026
AIGH Capital Management LLC1.13M2.7%US$2.76MSep 30, 2026
Essex Investment Management Co LLC1.1M2.6%US$2.7MSep 30, 2026
Silverberg Bernstein Capital Management LLC1.02M2.4%US$2.5MSep 30, 2026
BlackRock554K1.3%US$1.36MSep 30, 2026
Horizon Kinetics Asset Management LLC460K1.1%US$1.13MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Geode Capital403K0.96%US$987KSep 30, 2026
Taylor Frigon Capital Management LLC395K0.94%US$969KSep 30, 2026
Renaissance Technologies383K0.91%US$939KSep 30, 2026
Legato Capital Management LLC342K0.81%US$837KSep 30, 2026
Kingsview Wealth Management, LLC217K0.52%US$532KSep 30, 2026
Millennium192K0.46%US$470KSep 30, 2026
Caption Management, LLC192K0.45%US$469KSep 30, 2026
Marshall Wace, LLP189K0.45%US$464KSep 30, 2026
Susquehanna179K0.42%US$438KSep 30, 2026
Sei Investments Co175K0.42%US$430KSep 30, 2026
State Street120K0.29%US$295KSep 30, 2026
Franklin Templeton95,8030.23%US$248KSep 30, 2026
Z3 Capital Partners, LLC88,1090.21%US$216KSep 30, 2026
Northern Trust78,5670.19%US$192KSep 30, 2026
RPg Family Wealth Advisory, LLC76,2500.18%US$187KSep 30, 2026
Hillsdale Investment Management Inc.75,2000.18%US$184KSep 30, 2026
Bridgeway Capital Management, LLC60,6860.14%US$149KSep 30, 2026
Integrated Quantitative Investments LLC58,2040.14%US$143KSep 30, 2026
Centiva Capital, LP58,1800.14%US$143KSep 30, 2026
Empowered Funds, LLC54,3850.13%US$133KSep 30, 2026
Acadian Asset Management LLC50,0380.12%US$118KSep 30, 2026
Goldman Sachs45,2980.11%US$111KSep 30, 2026
Perkins Capital Management Inc45,0000.11%US$110KSep 30, 2026
Squarepoint Ops LLC44,6010.11%US$109KSep 30, 2026
Hrt Financial LP41,7310.10%US$102KSep 30, 2026
Morgan Stanley33,0300.08%US$80,923Sep 30, 2026
Schonfeld Strategic Advisors LLC25,4120.06%US$62,259Sep 30, 2026
P.A.W. Capital Corp25,0000.06%US$61,250Sep 30, 2026
Jefferies Financial Group Inc.24,5000.06%US$60,025Sep 30, 2026
Creative Planning21,9000.05%US$53,655Sep 30, 2026
HighTower Advisors, LLC20,8940.05%US$51,190Sep 30, 2026
Joel Isaacson & Co., LLC20,5000.05%US$50,225Sep 30, 2026
Nwam LLC17,2390.04%US$42,236Sep 30, 2026
Catalyst Funds Management Pty Ltd16,5180.04%US$40,469Sep 30, 2026
Virtu Financial LLC15,4950.04%US$38,000Sep 30, 2026
Jane Street13,6440.03%US$33,427Sep 30, 2026
Connor, Clark & Lunn Investment Management Ltd.10,5990.03%US$25,968Sep 30, 2026
Scholtz & Company, LLC10,0000.02%US$24,500Sep 30, 2026
UBS6,4900.02%US$15,900Sep 30, 2026
Osaic Holdings, Inc.6,0000.01%US$15,600Sep 30, 2026

This page holds 50 of 67 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund1.1M2.6%US$4.92MJun 30, 2026
Royce Small-Cap Opportunity Fund699K1.7%US$3.14MJun 30, 2026
Royce Micro-Cap Fund587K1.4%US$2.63MJun 30, 2026
Vanguard Extended Market Index Fund400K0.95%US$1.79MJun 30, 2026
1290 Essex Small Cap Growth Fund276K0.66%US$1.13MJul 31, 2026
Royce Capital Fund - Micro-Cap Portfolio215K0.51%US$966KJun 30, 2026
Fidelity Extended Market Index Fund180K0.43%US$718KMay 31, 2026
Taylor Frigon Core Growth Fund128K0.30%US$513KMay 31, 2026
iShares Micro-Cap ETF122K0.29%US$549KJun 30, 2026
Siit Small Cap II Fund87,9000.21%US$351KMay 31, 2026
All 20 holders
HolderSharesOf the companyValueAs of
Fidelity Total Market Index Fund56,1180.13%US$224KMay 31, 2026
Ultra-Small Company Market Fund55,3000.13%US$248KJun 30, 2026
Fidelity Series Total Market Index Fund52,6450.12%US$210KMay 31, 2026
Fidelity Nasdaq Composite Index Fund23,3270.06%US$93,191May 31, 2026
Venerable US Small Cap Fund22,0330.05%US$98,928Jun 30, 2026
Vanguard Balanced Index Fund21,3590.05%US$95,902Jun 30, 2026
Vanguard Institutional Total Stock Market Index Fund18,3130.04%US$82,225Jun 30, 2026
1290 VT Micro Cap Portfolio8,1760.02%US$36,710Jun 30, 2026
Victory Extended Market Index Fund4,198<0.01%US$17,212Jul 31, 2026
Dimensional U.S. Core Equity 2 ETF713<0.01%US$2,923Jul 31, 2026

Big stakes

StakeStakeSharesDateFiling
Nantahala Capital Management, LLC9.99%4.11MDec 31, 2025Schedule 13G
Royce & Associates LP7.81%3.27MJun 30, 2026Schedule 13G
Kanen Wealth Management LLC5.40%2.28MOct 21, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Stavros G. Vizirgianakis
Other companies: Xtant Medical Holdings, Inc. (Director · Since at least Aug 25, 2022); Medinotec Inc. (Director · Apr 16, 2025 – Apr 16, 2025 · Past); Bioventus Inc. (Director · Oct 29, 2021 – Jun 16, 2022 · Past); Misonix Inc (President and CEO, Director · May 7, 2013 – Oct 29, 2021 · Past)
Chairman of the Board · Since at least May 7, 2024
Mathew C Hill
Other companies: PDS Biotechnology Corporation (Chief Financial Officer · Oct 18, 2021 – Jan 5, 2023 · Past); STRATA Skin Sciences, Inc. (Chief Financial Officer · May 15, 2018 – Nov 13, 2020 · Past); Ep Medsystems Inc (Chief Financial Officer · Dec 12, 2006 – Dec 12, 2006 · Past)
Chief Financial Officer · Since at least Dec 4, 2023
Minnie Baylor-Henry
Other companies: Scpharmaceuticals Inc (Director · Since at least Jun 14, 2022); Lantheus Holdings, Inc. (Director · Since at least May 6, 2022); Paratek Pharmaceuticals Inc (Director · Feb 8, 2023 – Sep 21, 2023 · Past)
Director · Since at least Aug 11, 2022
Ian Sheffield
Other companies: Invivyd, Inc. (Director · Since at least Aug 30, 2026); Fractyl Health, Inc. (Director · Since at least Sep 2, 2025)
Director · Dec 13, 2013 – May 6, 2015 · Past
Lawrence J. Waldman
Other companies: CVD Equipment Corporation (Director · Since at least Oct 5, 2016); Comtech Telecommunications Corp. (Lead Independent Director · Since at least Aug 31, 2015)
Director · Since at least Mar 18, 2011
Charles T Orsatti
Other companies: Djo Inc (Director · Jun 7, 2006 – Nov 20, 2007 · Past)
Director · May 6, 2015 – Jul 28, 2016 · Past
Gary Pickett
Other companies: First Choice Healthcare Solutions, Inc. (Chief Financial Officer · Nov 3, 2014 – Nov 3, 2014 · Past)
Chief Financial Officer · Mar 29, 2007 – Jul 12, 2012 · Past
Scott Richard Davidson
Other companies: WaferGen Bio-systems Inc (Director · Jan 12, 2012 – Nov 15, 2013 · Past)
Director · Jul 28, 2016 – Jul 28, 2016 · Past
Alfred V GrecoDirector · May 5, 2005 – May 12, 2005 · Past
Andrew MakridesChairman of the Board · Since at least Dec 5, 2008
All 28 people
PersonSeat
August LentricchiaDirector · Aug 9, 2007 – Dec 9, 2013 · Past
Charles D Goodwin IIChief Executive Officer, Director · Since at least Dec 15, 2017
Charlie GoodwinPresident and Chief Executive Officer · Since at least Nov 5, 2026
Craig A SwandalDirector · Mar 9, 2018 – Aug 8, 2024 · Past
George W KromerDirector · May 5, 2005 – Oct 1, 2013 · Past
Jay D EwersChief Financial Officer · Jun 15, 2015 – Jan 4, 2018 · Past
John C AndresDirector · Aug 30, 2018 – Aug 8, 2024 · Past
John J McCarthy IIIChief CommercializationOfficer · Dec 22, 2015 – May 1, 2017 · Past
J Robert SaronPresident, Director · Sep 19, 2014 – May 1, 2017 · Past
Michael GeraghtyDirector · Aug 8, 2024 – Aug 8, 2024 · Past
Moshe CitronowiczSr. V.P. of Operations · Since at least Jan 1, 2008
Randy D RossiDirector · May 5, 2005 – Aug 28, 2008 · Past
Robert GershonChief Executive Officer, Director · Dec 13, 2013 – May 1, 2017 · Past
Shawn David RomanChief Operating Officer · Since at least Nov 6, 2024
Steven MacLarenDirector · Jul 8, 2010 – Jul 8, 2010 · Past
Tara SembChief Financial Officer · Jan 2, 2019 – Jan 11, 2023 · Past
Todd HornsbyExecutive Vice President · Jan 6, 2019 – Jan 10, 2024 · Past
Wendy Lauren LevineDirector · Since at least Aug 25, 2021

Open People

Log in to ask 6ix AI your own questions about Apyx Medical Corporation.